Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?

Trial Profile

Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Dapagliflozin (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
    • 10 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.
    • 16 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top